Rosemary A Crane is Director of Catalent, Inc.. Currently has a direct ownership of 23,873 shares of CTLT, which is worth approximately $1.52 Million. The most recent transaction as insider was on Oct 27, 2023, when has been sold 6,993 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.9K
0% 3M change
0% 12M change
Total Value Held $1.52 Million

Rosemary A Crane Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 27 2023
BUY
Grant, award, or other acquisition
-
6,993 Added 22.66%
23,873 Common Stock
Oct 27 2022
BUY
Grant, award, or other acquisition
-
4,149 Added 19.73%
16,880 Common Stock
Oct 28 2021
BUY
Grant, award, or other acquisition
-
1,402 Added 9.92%
12,731 Common Stock
Oct 29 2020
BUY
Grant, award, or other acquisition
-
2,125 Added 15.79%
11,329 Common Stock

Also insider at

TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD Healthcare
TARS
Tarsus Pharmaceuticals, Inc. Healthcare
CERT
Certara, Inc. Healthcare
RAC

Rosemary A Crane

Director
Princeton, NJ

Track Institutional and Insider Activities on CTLT

Follow Catalent, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTLT shares.

Notify only if

Insider Trading

Get notified when an Catalent, Inc. insider buys or sells CTLT shares.

Notify only if

News

Receive news related to Catalent, Inc.

Track Activities on CTLT